Search For "controller"
DGCA suspends air traffic controller in near mid-air collision at Bengalur
Updated : 3 years, 9 months ago IST
New Delhi [India], May 30 (ANI): The Directorate General of Civil Aviation (DGCA) on Monday suspended the Air Traffic Control officer's license for a period of three months, who was involved in 'a breach of separation' at Bengaluru airport.
Read More
Bharat Biotech seeks DCGI's permission to conduct Covaxin booster trials i
Updated : 3 years, 10 months ago IST
New Delhi [India], May 4 (ANI): Hyderabad-based pharma company Bharat Biotech has sought permission from the Drugs Controller General of India (DCGI) to conduct trials of Covaxin as COVID-19 vaccine booster dose in the 2-18 age group, sources said.
Read More
NTAGI to review data of COVID-19 vaccines for children aged 5-12 years: So
Updated : 3 years, 10 months ago IST
New Delhi [India], May 2 (ANI): The COVID-19 working group of the National Technical Advisory Group on Immunisation (NTAGI) will review the data of COVID-19 vaccines for the children aged 5 to 12 years on May 4, said sources on Monday.
Read More
SEC seeks more data from Serum Institute over COVID vaccine Covovax for 7-
Updated : 3 years, 10 months ago IST
New Delhi [India], April 30 (ANI): The Drugs Controller General of India's (DCGI) subject expert committee on Friday sought more data from Pune based Serum Institute of India (SII) on the Covovax vaccine for the age group of 7-12 years.
Read More
Paediatricians welcome COVID vaccines for kids, say parents mustn't hesita
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
DCGI approves COVID-19 vaccine Covaxin for children aged 6-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted an emergency use authorisation (EUA) to Bharat Biotech's Covaxin for the age group of 6-12 years.
Read More
Corbevax COVID-19 vaccine gets DCGI's nod for children aged 5-12
Updated : 3 years, 10 months ago IST
Hyderabad (Telangana) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company on Tuesday.
Read More
DCGI grants EUA to ZycovD COVID vaccine for two-dose regimen for children
Updated : 3 years, 10 months ago IST
Ahmedabad (Gujarat) [India], April 26 (ANI): The Drugs Controller General of India (DCGI) on Tuesday granted Emergency Use Authorisation (EUA) to Zydus Cadila vaccine (ZycovD) for COVID-19 as a two-dose vaccine for children above the age of 12 years, said Zydus Lifesciences Ltd., the phar
Read More
DCGI gives emergency use authorisation to Covaxin for 6-12 age group
Updated : 3 years, 10 months ago IST
New Delhi [India], April 26 (ANI): The Drugs Controller General of India (DCGI) gives restricted emergency use authorisation to Covaxin for the 6-12 age group.
Read More
Bharat Biotech asked to provide more data on COVID-19 vaccine Covaxin for
Updated : 3 years, 11 months ago IST
New Delhi [India], April 22 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has asked Bharat Biotech for additional data on its COVID-19 vaccine, Covaxin, for administering it to children aged between 2-12 years, sources said.
Read More
Subject Expert Panel recommends Corbevax COVID-19 vaccines for children ag
Updated : 3 years, 11 months ago IST
New Delhi [India], April 21 (ANI): The Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) has recommended restricted emergency use of Biological E's Corbevax COVID-19 vaccine for children aged 5-11, said sources on Thursday.
Read More
Expert panel of DCGI holds meet to discuss recommendations to use COVID-19
Updated : 3 years, 11 months ago IST
New Delhi [India], April 21 (ANI): The meeting of the Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI) is underway to discuss recommendations on restricted emergency use of Bharat Biotech's Covaxin and Biological E's Corbevax COVID-19 vaccine for children aged
Read More